CJC-1295
Conveniently located to serve Beverly Hills, Hollywood, Los Angeles, NYC, and Miami.
CJC-1295 is a synthetic analogue of GHRH and growth hormone secretagogue (GHS) that has research applications in the fields of growth hormone deficiency, sleep quality, and anti-aging. Inside, researchers will find what they must know about CJC-1295, including results from clinical trials.
Featured on:
What is CJC-1295?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) and a growth hormone secretagogue (GHS) that was developed in the mid-2000s by ConjuChem Technologies [1]. Originally designed to treat obesity issues in HIV/AIDS patients, the peptide has since been shown to effectively treat growth hormone deficiency, improve sleep quality, and promote longevity, and is classified as a prohibited substance under Section S2 of the World Anti-Doping Agency’s (WADA) Prohibited List [2, 3].
WHAT IS IPAMORELIN?
is a hormone secretagogue, meaning it helps excrete hormones into the bloodstream while simulating the pituitary gland to produce them. It serves other functions as well. Ipamorelin is associated with improved cognitive skills, memory, pain relief, and internal body temperature regulation along with growth and muscle development.
HOW DOES CJC 1295 WORK?
Ipamorelin and CJC 1295 are often used together to stimulate muscle development. The combination works by increasing the blood level of hormones associated with growth. It can increase muscle mass and strength, decrease body fat, improve injury recovery time, and even improve sleep quality and cognitive function.
WHY WOULD I WANT TO USE CJC 1295/IPAMORELIN?
CJC 1295/Ipamorelin has been shown to:
- Increase bone density
- Strengthen the cardiovascular system
- Increase muscle mass
- Improve ability to burn fat
- Increase sex drive
- Improve recovery and repair from injuries
- Regenerate nerve tissues
- Strengthen the immune system
- Improve cognition and memory
- Outperforms sermorelin due to longer half-life and increased efficacy
